Noah Rosenberg
2021
In 2021, Noah Rosenberg earned a total compensation of $2.8M as Former Chief Medical Officer at Retrophin, a 68% increase compared to previous year.
Compensation breakdown
| Option Awards | $791,194 |
|---|---|
| Salary | $507,766 |
| Stock Awards | $403,200 |
| Other | $1,078,448 |
| Total | $2,780,608 |
Rosenberg received $1.1M in other compensation, accounting for 39% of the total pay in 2021.
Rosenberg also received $791.2K in option awards, $507.8K in salary and $403.2K in stock awards.
Rankings
In 2021, Noah Rosenberg's compensation ranked 4,725th out of 12,415 executives tracked by ExecPay. In other words, Rosenberg earned more than 61.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,725 out of 12,415 | 62nd |
Division Manufacturing | 1,968 out of 5,505 | 64th |
Major group Chemicals And Allied Products | 827 out of 2,375 | 65th |
Industry group Drugs | 740 out of 2,096 | 65th |
Industry Pharmaceutical Preparations | 528 out of 1,546 | 66th |
Pay ratio
| Noah Rosenberg's Pay | $2,780,608 |
|---|---|
| Median Employee's Pay | $309,779 |
| Pay Ratio | 9to 1 |
In 2021, the annual total compensation of Noah Rosenberg was $2,780,608.
The annual total compensation of the median employee at Retrophin was $309,779.
The ratio of Noah Rosenberg's pay to the pay of median employee was therefore 9 to one.
Source: SEC filing on April 4, 2022.
Rosenberg's colleagues
We found four more compensation records of executives who worked with Noah Rosenberg at Retrophin in 2021.